Back to today’s briefing

Story perspectives

New Drug Boosts Alertness for Early-Morning Workers

2/2/2026

48 8

Summary

Story summary

A new study finds solriamfetol reduces sleepiness for early-morning shift workers compared with placebo.
The trial involved 78 workers who start shifts between 3 a.m. and 7 a.m.
Senior researcher Dr. Charles Czeisler notes this trial is the first to address treatment for shift work disorder in this demographic.
Findings suggest solriamfetol may improve work productivity and overall functioning for these essential workers.

1 of 1

Story summary

A new study finds solriamfetol reduces sleepiness for early-morning shift workers compared with placebo.
The trial involved 78 workers who start shifts between 3 a.m. and 7 a.m.
Senior researcher Dr. Charles Czeisler notes this trial is the first to address treatment for shift work disorder in this demographic.
Findings suggest solriamfetol may improve work productivity and overall functioning for these essential workers.